Javier E. Banchs

Same Score, Different Risk: Toward Individualized Anticoagulation After Successful AF Ablation: A Narrative Review for the Post-Ablation Antithrombotic Decision in Atrial Fibrillation

Moez Alnazeer, Jerry Fan, Peter Cheung, Javier E. Banchs et autres

Current guidelines recommend that long-term oral anticoagulation (OAC) after atrial fibrillation (AF) ablation be guided by CHA2DS2-VASc rather than ablation success. However, two recent randomized trials, ALONE-AF and OCEAN, observed very low stroke and systemic embolism rates in rigorously selected post-ablation populations. …

us (code pays fourni par la source)

Trust, but verify: lessons from cardiac CT imaging after surgical left atrial appendage exclusion

Moez Alnazeer, Javier E. Banchs

After surgical left atrial appendage (LAA) closure for patients with atrial fibrillation, the clinical dilemma rarely ends in the operating room. It reappears months later in clinic as a deceptivel...

us (code pays fourni par la source)

Outcomes of patients with cardiogenic shock and atrial fibrillation receiving pulmonary vein isolation or AV node ablation and cardiac resynchronization

Bright Izekor, Kadilee Adams, Kendall Hammonds, Jessica Lee et autres

us (code pays fourni par la source)

ID: 4348379 MAPPING THE INVISIBLE: SPATIAL ERP MAPPING AS A TARGETABLE MARKER OF ARRHYTHMOGENIC SUBSTRATE

Moez Alnazeer, Peter Y. K. Cheung, Ajay Tripuraneni, Greg Olsovsk et autres

Conventional electrophysiology mapping techniques—voltage, activation, and conduction velocity—identify structural and timing abnormalities but do not characterize tissue recovery. Yet reentry is governed not only by conduction delay or fixed obstacles but by spatial dispersion in refractoriness. Without direct visualization of recovery gradients, …

Prediction of coronary no-reflow from the surface electrocardiogram

Javier E. Banchs

Since the first electrocardiogram recorded by Augustus Waller in 1887,1 its diagnostic value has not stopped enriching medicine.2 From the diagnosis of acute myocardial infarction, cardiac arrhythm...

us (code pays fourni par la source)

PO-FP-048 FDA ADVISORIES ON CARDIAC IMPLANTABLE ELECTRONIC DEVICES FROM 2014-2024

Alexandru Stoica, Srusthi Gopani, Javier E. Banchs, Jignesh Shah

CATHETER ABLATION FOR ATRIAL FIBRILLATION IN CARDIOGENIC SHOCK

Ayesha Mirza, Marcus Stepney, Naser Asfoor, Laith Wahab et autres

us (code pays fourni par la source)

Dietary interventions in the management of atrial fibrillation

M Nabil, Leanne Rychlik, A. Nicholson, Peter Cheung et autres

Atrial fibrillation (AF) represents the most common cardiac arrhythmia with significant morbidity and mortality implications. It is a common cause of hospital admissions, significantly impacts quality of life, increases morbidity and decreases life expectancy. Despite advancements in treatment options, prevalence of AF …

us (code pays fourni par la source)

PO-02-057 COMPREHENSIVE VALIDATION OF EINTHOVEN'S AND GOLDBERGER'S ELECTROCARDIOGRAPHIC LEAD SYSTEMS USING THE PTB-XL DATASET

Tanay Chitlur, Jerry Fan, Javier E. Banchs, Yu‐Sheng Chen et autres

Intracardiac Ultrasound and Mapping Integration-Guided Endomyocardial Biopsy for the Diagnosis of Myocardial Melanoma Metastasis

Jerry Fan, Christopher Perez, R. Jay Widmer, N. Q. Vinh et autres

[Figure: see text]

us (code pays fourni par la source)

Posttransplant atrial fibrillation: Evidence of early posttransplant recipient‐to‐donor atrioatrial connections

Bright Izekor, Christopher Perez, Javier E. Banchs, Gregory Olsovsky

INTRODUCTION: Atrial fibrillation and atrial flutter originating from the donor s heart is a commonly reported complication post heart transplant. Atrial tachyarrhythmia originating from the recipient s heart, propagated through recipient-to-donor connections, is rare with only few cases reported in the literature; …

us (code pays fourni par la source)

Left atrial appendage exclusion, here to stay

Javier E. Banchs

PROTECT AF1 and PREVAIL2 were the clinical trials that ultimately led to the approval by the Food and Drug Administration of the Watchman left atrial appendage occlusion (LAAO) device for clinical ...

us (code pays fourni par la source)